Clinical Trial Update: The Safety and Tolerability of Sub-retinal Transplantation of SCNT-hES-RPE Cells in Patients With Advanced Dry AMD [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and tolerability of sub-retinal transplantation of SCNT-hES-derived retinal pigment epithelium (RPE) cells in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• SCNT-hES-RPE cells

Snippet

Sponsor: CHA University | Conditions: Dry Age Related Macular Degeneration | Phase 1 | Status: UNKNOWN